Clinical trial
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease…
NCT00212355 · Nobelpharma, Industry · Completed
Key facts
| NCT number | NCT00212355 |
|---|---|
| Title | Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. |
| Official title | Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan. |
| Lead sponsor | Nobelpharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Wilson's Disease |
| Intervention type | Drug |
| Interventions | NPC-02 |
| Enrollment | 37 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 5, 2025 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: